Format
Sort by
Items per page

Send to

Choose Destination

See also: CD79B CD79b molecule in the Gene database

cd79b in Homo sapiensMus musculusRattus norvegicusAll 266 Gene records

Search results

Items: 1 to 20 of 938

1.

Precision medicine for human cancers with Notch signaling dysregulation (Review).

Katoh M, Katoh M.

Int J Mol Med. 2020 Feb;45(2):279-297. doi: 10.3892/ijmm.2019.4418. Epub 2019 Dec 4.

PMID:
31894255
2.

Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.

King RL, Goodlad JR, Calaminici M, Dotlic S, Montes-Moreno S, Oschlies I, Ponzoni M, Traverse-Glehen A, Ott G, Ferry JA.

Virchows Arch. 2019 Dec 20. doi: 10.1007/s00428-019-02698-3. [Epub ahead of print] Review.

PMID:
31863183
3.

Cancer biomarkers for targeted therapy.

Liu D.

Biomark Res. 2019 Nov 15;7:25. doi: 10.1186/s40364-019-0178-7. eCollection 2019.

4.

Genomic Alterations In Primary Cardiac Diffuse Large B Cell Lymphoma: A Case Report And Literature Review.

Zhang J, Lin X, Li Y, Zhang R.

Onco Targets Ther. 2019 Nov 4;12:9085-9092. doi: 10.2147/OTT.S227122. eCollection 2019.

5.

IRF4-rearranged Large B-cell lymphoma (LBCL) has a genomic profile distinct to other LBCL in children and young adults.

Ramis-Zaldivar JE, Gonzalez-Farre B, Balagué O, Celis V, Nadeu F, Salmeron-Villalobos J, Andres M, Martin-Guerrero I, Garrido-Pontnou M, Gaafar A, Suñol M, Barcena C, Garcia-Bragado F, Andión M, Azorín D, Astigarraga I, Sagaseta de Ilurdoz M, Sábado C, Gallego S, Verdu-Amorós J, Fernandez-Delgado R, Perez V, Tapia G, Mozos A, Torrent M, Solano-Páez P, Rivas-Delgado A, Dlouhy I, Clot G, Enjuanes A, López-Guillermo A, Galera PK, Oberley MJ, Maguire A, Ramsower C, Rimsza LM, Quintanilla-Martinez L, Jaffe ES, Campo E, Salaverria I.

Blood. 2019 Nov 18. pii: blood.2019002699. doi: 10.1182/blood.2019002699. [Epub ahead of print]

PMID:
31738823
6.

Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?

Falay M, Serdar MA, Dalgali H, Uçar MA, Dagdaş S, Özet G.

Clin Lab. 2019 Nov 1;65(11). doi: 10.7754/Clin.Lab.2019.190316.

PMID:
31710447
7.

Genetic Approaches for Definitive Diagnosis of Agammaglobulinemia in Consanguineous Families.

Ben-Ali M, Kechout N, Mekki N, Yang J, Chan KW, Barakat A, Aadam Z, Gamara J, Gargouri L, Largueche B, BelHadj-Hmida N, Nedri A, Ameur HB, Mellouli F, Boukari R, Bejaoui M, Bousfiha A, Ben-Mustapha I, Lau YL, Barbouche MR.

J Clin Immunol. 2019 Nov 6. doi: 10.1007/s10875-019-00706-4. [Epub ahead of print]

PMID:
31696364
8.

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Sehn LH, Herrera AF, Flowers CR, Kamdar MK, McMillan A, Hertzberg M, Assouline S, Kim TM, Kim WS, Ozcan M, Hirata J, Penuel E, Paulson JN, Cheng J, Ku G, Matasar MJ.

J Clin Oncol. 2020 Jan 10;38(2):155-165. doi: 10.1200/JCO.19.00172. Epub 2019 Nov 6.

PMID:
31693429
9.

Morphologic Patterns and the Correlation With MYD88 L265P, CD79B Mutations in Primary Adrenal Diffuse Large B-Cell Lymphoma.

Chen Z, Zou Y, Liu W, Guan P, Tao Q, Xiang C, Zhang W, Ye Y, Yan J, Zhao S.

Am J Surg Pathol. 2019 Oct 11. doi: 10.1097/PAS.0000000000001386. [Epub ahead of print]

PMID:
31609782
10.

Effects of Cell Differentiation on the Phagocytic Activities of IgM+ B Cells in a Teleost Fish.

Wu L, Kong L, Yang Y, Bian X, Wu S, Li B, Yin X, Mu L, Li J, Ye J.

Front Immunol. 2019 Sep 19;10:2225. doi: 10.3389/fimmu.2019.02225. eCollection 2019.

11.

Molecular profiling of primary central nervous system lymphomas - predictive and prognostic value?

Ho KG, Grommes C.

Curr Opin Neurol. 2019 Dec;32(6):886-894. doi: 10.1097/WCO.0000000000000759.

PMID:
31592789
12.

Plasmablastic Lymphoma, a Rare Entity in Bone Marrow with Unusual Immunophenotype and Challenging Differential Diagnosis.

Al Shaarani M, Shackelford RE, Master SR, Mills GM, AlZubaidi Y, Mamilly A, Wei EX.

Case Rep Hematol. 2019 Sep 2;2019:1586328. doi: 10.1155/2019/1586328. eCollection 2019.

13.

Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia.

Salem DA, Stetler-Stevenson M.

Methods Mol Biol. 2019;2032:311-321. doi: 10.1007/978-1-4939-9650-6_17.

PMID:
31522426
14.

Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19.

Ormhøj M, Scarfò I, Cabral ML, Bailey SR, Lorrey SJ, Bouffard AA, Castano AP, Larson RC, Riley LS, Schmidts A, Choi BD, Andersen RS, Cédile O, Nyvold CG, Christensen JH, Gjerstorff MF, Ditzel HJ, Weinstock DM, Barington T, Frigault MJ, Maus MV.

Clin Cancer Res. 2019 Dec 1;25(23):7046-7057. doi: 10.1158/1078-0432.CCR-19-1337. Epub 2019 Aug 22.

PMID:
31439577
15.

Mutations found in cell-free DNAs of patients with malignant lymphoma at remission can derive from clonal hematopoiesis.

Suehara Y, Sakata-Yanagimoto M, Hattori K, Kusakabe M, Nanmoku T, Sato T, Noguchi M, Chiba S.

Cancer Sci. 2019 Oct;110(10):3375-3381. doi: 10.1111/cas.14176. Epub 2019 Sep 12.

16.

Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes.

Zhou Y, Xu Z, Lin W, Duan Y, Lu C, Liu W, Su W, Yan Y, Liu H, Liu L, Zhong M, Zhou J, Zhu H.

Front Oncol. 2019 Jul 25;9:683. doi: 10.3389/fonc.2019.00683. eCollection 2019.

17.

Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network.

Varettoni M, Boveri E, Zibellini S, Tedeschi A, Candido C, Ferretti VV, Rizzo E, Doni E, Merli M, Farina L, Goldaniga M, Gallì A, Rattotti S, Frustaci AM, Deodato M, Bandiera L, Isimbaldi G, Uccella S, Cabras AD, Gianelli U, Baldini L, Paulli M, Arcaini L.

Am J Hematol. 2019 Nov;94(11):1193-1199. doi: 10.1002/ajh.25600. Epub 2019 Sep 9.

PMID:
31378966
18.

Data showing atherosclerosis-associated differentially methylated regions are often at enhancers.

Lacey M, Baribault C, Ehrlich KC, Ehrlich M.

Data Brief. 2019 Mar 7;23:103812. doi: 10.1016/j.dib.2019.103812. eCollection 2019 Apr.

19.

Polatuzumab Vedotin: First Global Approval.

Deeks ED.

Drugs. 2019 Sep;79(13):1467-1475. doi: 10.1007/s40265-019-01175-0. Review. Erratum in: Drugs. 2019 Nov;79(16):1829.

20.

Immunological characteristics of Interleukin-2 receptor subunit beta (IL-2Rβ) in flounder (Paralichtlys olivaceus): Implication for IL-2R function.

Zhou X, Xing J, Tang X, Sheng X, Zhan W.

Fish Shellfish Immunol. 2019 Oct;93:641-651. doi: 10.1016/j.fsi.2019.07.059. Epub 2019 Jul 22.

PMID:
31344456

Supplemental Content

Loading ...
Support Center